Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 63
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
IssuerBlackrock
ETF TickerBTEE(USD) LSE
ETF TickerBTEE.L(GBP) LSE

Holdings detail for RNA

Stock NameAvidity Biosciences Inc
TickerRNA(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS05370A1088

Show aggregate RNA holdings

News associated with RNA

Avidity Biosciences, Inc. (NASDAQ:RNA) Shares Purchased by Hsbc Holdings PLC
Hsbc Holdings PLC lifted its holdings in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 111.4% in the 4th quarter, Holdings Channel.com reports. The fund owned 17,519 shares of the biotechnology company’s stock after buying an additional 9,230 shares during the quarter. Hsbc Holdings PLC’s holdings in Avidity Biosciences were worth $507,000 at the end […] - 2025-05-07 08:00:55
First Trust Advisors LP Buys 45,254 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
First Trust Advisors LP lifted its stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 110.0% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 86,395 shares of the biotechnology company’s stock after acquiring an additional 45,254 shares during the period. First Trust Advisors LP […] - 2025-05-05 08:08:59
Envestnet Asset Management Inc. Sells 3,931 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
Envestnet Asset Management Inc. decreased its stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 10.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 33,132 shares of the biotechnology company’s stock after selling 3,931 shares during the quarter. Envestnet […] - 2025-05-02 07:24:46
Raymond James Financial Inc. Makes New $5.78 Million Investment in Avidity Biosciences, Inc. (NASDAQ:RNA)
Raymond James Financial Inc. purchased a new stake in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 198,907 shares of the biotechnology company’s stock, valued at approximately $5,784,000. Other hedge funds and […] - 2025-04-25 09:43:06
Legal & General Group Plc Has $2.97 Million Stake in Avidity Biosciences, Inc. (NASDAQ:RNA)
Legal & General Group Plc lifted its position in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 7.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 102,100 shares of the biotechnology company’s stock after purchasing an additional 6,937 shares […] - 2025-04-24 08:06:51
Summit Investment Advisors Inc. Buys 666 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
Summit Investment Advisors Inc. raised its stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 6.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 11,611 shares of the biotechnology company’s stock after purchasing an additional 666 shares during the period. […] - 2025-04-21 07:56:51
Renaissance Technologies LLC Acquires 69,300 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
Renaissance Technologies LLC lifted its holdings in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 48.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 211,200 shares of the biotechnology company’s stock after acquiring an additional 69,300 shares during the period. Renaissance […] - 2025-04-20 08:00:56
Alliancebernstein L.P. Decreases Position in Avidity Biosciences, Inc. (NASDAQ:RNA)
Alliancebernstein L.P. decreased its holdings in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 25.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 127,770 shares of the biotechnology company’s stock after selling 42,914 shares during the quarter. Alliancebernstein L.P.’s holdings in Avidity […] - 2025-04-15 07:50:50
Avidity Biosciences, Inc. (NASDAQ:RNA) Shares Sold by JPMorgan Chase & Co.
JPMorgan Chase & Co. reduced its position in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 3.6% in the 4th quarter, Holdings Channel reports. The firm owned 450,144 shares of the biotechnology company’s stock after selling 16,941 shares during the period. JPMorgan Chase & Co.’s holdings in Avidity Biosciences were worth $13,090,000 as of its […] - 2025-04-14 08:13:06
Needham & Company LLC Reaffirms “Buy” Rating for Avidity Biosciences (NASDAQ:RNA)
Avidity Biosciences (NASDAQ:RNA – Get Free Report)‘s stock had its “buy” rating restated by Needham & Company LLC in a report released on Wednesday,Benzinga reports. They currently have a $60.00 target price on the biotechnology company’s stock. Needham & Company LLC’s target price would indicate a potential upside of 148.86% from the stock’s current price. […] - 2025-04-11 09:22:53
Sei Investments Co. Sells 19,149 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
Sei Investments Co. lessened its stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 47.0% during the 4th quarter, HoldingsChannel.com reports. The fund owned 21,554 shares of the biotechnology company’s stock after selling 19,149 shares during the period. Sei Investments Co.’s holdings in Avidity Biosciences were worth $627,000 as of its most […] - 2025-04-09 07:28:50
Avidity Biosciences, Inc. (NASDAQ:RNA) Shares Purchased by Schroder Investment Management Group
Schroder Investment Management Group boosted its stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 99.7% in the fourth quarter, Holdings Channel reports. The fund owned 61,480 shares of the biotechnology company’s stock after purchasing an additional 30,697 shares during the period. Schroder Investment Management Group’s holdings in Avidity Biosciences were worth […] - 2025-04-07 08:46:59
Mitsubishi UFJ Asset Management Co. Ltd. Has $171,000 Holdings in Avidity Biosciences, Inc. (NASDAQ:RNA)
Mitsubishi UFJ Asset Management Co. Ltd. decreased its stake in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 36.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,621 shares of the biotechnology company’s stock after selling 3,292 shares during […] - 2025-04-04 08:55:03
KLP Kapitalforvaltning AS Acquires New Position in Avidity Biosciences, Inc. (NASDAQ:RNA)
KLP Kapitalforvaltning AS purchased a new position in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 17,900 shares of the biotechnology company’s stock, valued at approximately $521,000. Other institutional investors and hedge funds […] - 2025-04-04 07:46:49
Avidity Biosciences, Inc. (NASDAQ:RNA) Shares Sold by Corient Private Wealth LLC
Corient Private Wealth LLC lowered its stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 6.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,525 shares of the biotechnology company’s stock after selling 731 shares during the quarter. […] - 2025-04-01 07:32:50
Cibc World Markets Corp Acquires New Holdings in Avidity Biosciences, Inc. (NASDAQ:RNA)
Cibc World Markets Corp bought a new stake in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 10,386 shares of the biotechnology company’s stock, valued at approximately $302,000. A number of other […] - 2025-03-25 08:48:52
Raymond James Financial Inc. Acquires Shares of 198,907 Avidity Biosciences, Inc. (NASDAQ:RNA)
Raymond James Financial Inc. bought a new stake in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 198,907 shares of the biotechnology company’s stock, valued at approximately $5,784,000. Other hedge funds have also recently made changes to their positions in the company. Victory Capital Management Inc. […] - 2025-03-25 08:08:48
Avidity Biosciences, Inc. (NASDAQ:RNA) Receives $66.69 Average Target Price from Analysts
Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) has received a consensus rating of “Buy” from the thirteen research firms that are covering the company, MarketBeat.com reports. Thirteen analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokers that have covered the stock in the last year is […] - 2025-03-21 05:20:54
Chardan Capital Reaffirms Buy Rating for Avidity Biosciences (NASDAQ:RNA)
Chardan Capital reissued their buy rating on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a research note published on Monday,Benzinga reports. The firm currently has a $65.00 price target on the biotechnology company’s stock. Other analysts have also recently issued research reports about the company. Scotiabank began coverage on Avidity Biosciences in a […] - 2025-03-18 05:54:46
Avidity Biosciences (NASDAQ:RNA) Earns Sector Outperform Rating from Analysts at Scotiabank
Scotiabank began coverage on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a report issued on Friday morning, MarketBeat Ratings reports. The brokerage issued a sector outperform rating and a $70.00 target price on the biotechnology company’s stock. Other analysts also recently issued research reports about the company. Chardan Capital reaffirmed a “buy” rating […] - 2025-03-10 05:50:51
Avidity Biosciences (NASDAQ:RNA) Shares Gap Down After Analyst Downgrade
Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report)’s stock price gapped down before the market opened on Monday after Barclays lowered their price target on the stock from $63.00 to $57.00. The stock had previously closed at $30.64, but opened at $29.90. Barclays currently has an overweight rating on the stock. Avidity Biosciences shares last […] - 2025-03-04 06:37:23
Barclays Cuts Avidity Biosciences (NASDAQ:RNA) Price Target to $57.00
Avidity Biosciences (NASDAQ:RNA – Free Report) had its target price cut by Barclays from $63.00 to $57.00 in a research report sent to investors on Friday morning,Benzinga reports. They currently have an overweight rating on the biotechnology company’s stock. Other equities research analysts also recently issued reports about the stock. Needham & Company LLC reissued […] - 2025-03-03 06:48:54
New York State Common Retirement Fund Buys 598 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
New York State Common Retirement Fund raised its stake in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 0.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 184,811 shares of the biotechnology company’s stock after acquiring an additional 598 shares during the period. […] - 2025-02-28 09:04:58
Avidity Biosciences, Inc. (NASDAQ:RNA) Shares Bought by State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D lifted its stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 8.1% during the fourth quarter, Holdings Channel reports. The firm owned 48,536 shares of the biotechnology company’s stock after buying an additional 3,638 shares during the period. State of New Jersey Common Pension […] - 2025-02-26 08:31:05
Analysts Set Avidity Biosciences, Inc. (NASDAQ:RNA) PT at $65.80
Shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) have earned a consensus recommendation of “Buy” from the ten ratings firms that are currently covering the stock, Marketbeat.com reports. Ten analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokerages that have covered the stock in the last […] - 2025-02-24 06:30:54
abrdn plc Buys 20,076 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
abrdn plc raised its stake in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 80.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 44,912 shares of the biotechnology company’s stock after purchasing an additional 20,076 shares during the period. abrdn plc’s holdings in […] - 2025-02-11 08:24:48

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) RNA holdings

DateNumber of RNA Shares HeldBase Market Value of RNA SharesLocal Market Value of RNA SharesChange in RNA Shares HeldChange in RNA Base ValueCurrent Price per RNA Share HeldPrevious Price per RNA Share Held
2025-05-08 (Thursday)57,237USD 1,642,130RNA holding increased by 144238USD 1,642,1300USD 144,238 USD 28.69 USD 26.17
2025-05-07 (Wednesday)57,237USD 1,497,892RNA holding decreased by -5152USD 1,497,8920USD -5,152 USD 26.17 USD 26.26
2025-05-06 (Tuesday)57,237USD 1,503,044RNA holding decreased by -344566USD 1,503,0440USD -344,566 USD 26.26 USD 32.28
2025-05-05 (Monday)57,237USD 1,847,610RNA holding increased by 4579USD 1,847,6100USD 4,579 USD 32.28 USD 32.2
2025-05-02 (Friday)57,237USD 1,843,031RNA holding decreased by -28047USD 1,843,0310USD -28,047 USD 32.2 USD 32.69
2025-05-01 (Thursday)57,237USD 1,871,078RNA holding increased by 2290USD 1,871,0780USD 2,290 USD 32.69 USD 32.65
2025-04-30 (Wednesday)57,237USD 1,868,788RNA holding increased by 28046USD 1,868,7880USD 28,046 USD 32.65 USD 32.16
2025-04-29 (Tuesday)57,237USD 1,840,742RNA holding increased by 54661USD 1,840,7420USD 54,661 USD 32.16 USD 31.205
2025-04-28 (Monday)57,237USD 1,786,081RNA holding increased by 20892USD 1,786,0810USD 20,892 USD 31.205 USD 30.84
2025-04-25 (Friday)57,237USD 1,765,189RNA holding decreased by -5151USD 1,765,1890USD -5,151 USD 30.84 USD 30.93
2025-04-24 (Thursday)57,237USD 1,770,340RNA holding increased by 14309USD 1,770,3400USD 14,309 USD 30.93 USD 30.68
2025-04-23 (Wednesday)57,237RNA holding increased by 200USD 1,756,031RNA holding increased by 76291USD 1,756,031200USD 76,291 USD 30.68 USD 29.45
2025-04-22 (Tuesday)57,037USD 1,679,740RNA holding increased by 53045USD 1,679,7400USD 53,045 USD 29.45 USD 28.52
2025-04-21 (Monday)57,037USD 1,626,695RNA holding increased by 106089USD 1,626,6950USD 106,089 USD 28.52 USD 26.66
2025-04-18 (Friday)57,037USD 1,520,606USD 1,520,6060USD 0 USD 26.66 USD 26.66
2025-04-17 (Thursday)57,037USD 1,520,606RNA holding increased by 51333USD 1,520,6060USD 51,333 USD 26.66 USD 25.76
2025-04-16 (Wednesday)57,037USD 1,469,273RNA holding decreased by -52474USD 1,469,2730USD -52,474 USD 25.76 USD 26.68
2025-04-15 (Tuesday)57,037USD 1,521,747RNA holding decreased by -13119USD 1,521,7470USD -13,119 USD 26.68 USD 26.91
2025-04-14 (Monday)57,037USD 1,534,866RNA holding increased by 75860USD 1,534,8660USD 75,860 USD 26.91 USD 25.58
2025-04-11 (Friday)57,037USD 1,459,006RNA holding increased by 83844USD 1,459,0060USD 83,844 USD 25.58 USD 24.11
2025-04-10 (Thursday)57,037RNA holding decreased by -1600USD 1,375,162RNA holding decreased by -79036USD 1,375,162-1,600USD -79,036 USD 24.11 USD 24.8
2025-04-09 (Wednesday)58,637USD 1,454,198RNA holding increased by 42219USD 1,454,1980USD 42,219 USD 24.8 USD 24.08
2025-04-08 (Tuesday)58,637RNA holding decreased by -200USD 1,411,979RNA holding decreased by -87188USD 1,411,979-200USD -87,188 USD 24.08 USD 25.48
2025-04-07 (Monday)58,837RNA holding decreased by -200USD 1,499,167RNA holding decreased by -69446USD 1,499,167-200USD -69,446 USD 25.48 USD 26.57
2025-04-04 (Friday)59,037RNA holding decreased by -1000USD 1,568,613RNA holding decreased by -218688USD 1,568,613-1,000USD -218,688 USD 26.57 USD 29.77
2025-04-02 (Wednesday)60,037USD 1,787,301RNA holding increased by 181912USD 1,787,3010USD 181,912 USD 29.77 USD 26.74
2025-04-01 (Tuesday)60,037RNA holding increased by 1748USD 1,605,389RNA holding decreased by -115302USD 1,605,3891,748USD -115,302 USD 26.74 USD 29.52
2025-03-31 (Monday)58,289RNA holding decreased by -591USD 1,720,691RNA holding decreased by -139917USD 1,720,691-591USD -139,917 USD 29.52 USD 31.6
2025-03-28 (Friday)58,880USD 1,860,608RNA holding decreased by -56525USD 1,860,6080USD -56,525 USD 31.6 USD 32.56
2025-03-27 (Thursday)58,880USD 1,917,133RNA holding increased by 30029USD 1,917,1330USD 30,029 USD 32.56 USD 32.05
2025-03-26 (Wednesday)58,880USD 1,887,104RNA holding decreased by -2944USD 1,887,1040USD -2,944 USD 32.05 USD 32.1
2025-03-25 (Tuesday)58,880USD 1,890,048RNA holding decreased by -70656USD 1,890,0480USD -70,656 USD 32.1 USD 33.3
2025-03-24 (Monday)58,880USD 1,960,704RNA holding increased by 144845USD 1,960,7040USD 144,845 USD 33.3 USD 30.84
2025-03-21 (Friday)58,880RNA holding increased by 2995USD 1,815,859RNA holding increased by 92924USD 1,815,8592,995USD 92,924 USD 30.84 USD 30.83
2025-03-20 (Thursday)55,885USD 1,722,935RNA holding decreased by -49737USD 1,722,9350USD -49,737 USD 30.83 USD 31.72
2025-03-19 (Wednesday)55,885USD 1,772,672RNA holding increased by 69297USD 1,772,6720USD 69,297 USD 31.72 USD 30.48
2025-03-18 (Tuesday)55,885USD 1,703,375RNA holding decreased by -187215USD 1,703,3750USD -187,215 USD 30.48 USD 33.83
2025-03-17 (Monday)55,885USD 1,890,590RNA holding increased by 152008USD 1,890,5900USD 152,008 USD 33.83 USD 31.11
2025-03-14 (Friday)55,885RNA holding decreased by -2992USD 1,738,582RNA holding decreased by -153136USD 1,738,582-2,992USD -153,136 USD 31.11 USD 32.13
2025-03-13 (Thursday)58,877USD 1,891,718RNA holding decreased by -28261USD 1,891,7180USD -28,261 USD 32.13 USD 32.61
2025-03-12 (Wednesday)58,877USD 1,919,979RNA holding increased by 178397USD 1,919,9790USD 178,397 USD 32.61 USD 29.58
2025-03-11 (Tuesday)58,877USD 1,741,582RNA holding decreased by -27083USD 1,741,5820USD -27,083 USD 29.58 USD 30.04
2025-03-10 (Monday)58,877USD 1,768,665RNA holding decreased by -14719USD 1,768,6650USD -14,719 USD 30.04 USD 30.29
2025-03-07 (Friday)58,877RNA holding decreased by -374USD 1,783,384RNA holding decreased by -14884USD 1,783,384-374USD -14,884 USD 30.29 USD 30.35
2025-03-06 (Thursday)59,251USD 1,798,268RNA holding increased by 47401USD 1,798,2680USD 47,401 USD 30.35 USD 29.55
2025-03-05 (Wednesday)59,251USD 1,750,867RNA holding increased by 58658USD 1,750,8670USD 58,658 USD 29.55 USD 28.56
2025-03-04 (Tuesday)59,251RNA holding decreased by -187USD 1,692,209RNA holding decreased by -44569USD 1,692,209-187USD -44,569 USD 28.56 USD 29.22
2025-03-03 (Monday)59,438USD 1,736,778RNA holding decreased by -84402USD 1,736,7780USD -84,402 USD 29.22 USD 30.64
2025-02-28 (Friday)59,438USD 1,821,180RNA holding increased by 92723USD 1,821,1800USD 92,723 USD 30.64 USD 29.08
2025-02-27 (Thursday)59,438USD 1,728,457RNA holding decreased by -33880USD 1,728,4570USD -33,880 USD 29.08 USD 29.65
2025-02-26 (Wednesday)59,438USD 1,762,337RNA holding increased by 29125USD 1,762,3370USD 29,125 USD 29.65 USD 29.16
2025-02-25 (Tuesday)59,438RNA holding increased by 374USD 1,733,212RNA holding decreased by -70012USD 1,733,212374USD -70,012 USD 29.16 USD 30.53
2025-02-24 (Monday)59,064USD 1,803,224RNA holding decreased by -34848USD 1,803,2240USD -34,848 USD 30.53 USD 31.12
2025-02-21 (Friday)59,064USD 1,838,072RNA holding decreased by -83280USD 1,838,0720USD -83,280 USD 31.12 USD 32.53
2025-02-20 (Thursday)59,064USD 1,921,352RNA holding increased by 37210USD 1,921,3520USD 37,210 USD 32.53 USD 31.9
2025-02-19 (Wednesday)59,064RNA holding decreased by -187USD 1,884,142RNA holding decreased by -11890USD 1,884,142-187USD -11,890 USD 31.9 USD 32
2025-02-18 (Tuesday)59,251USD 1,896,032RNA holding decreased by -18368USD 1,896,0320USD -18,368 USD 32 USD 32.31
2025-02-17 (Monday)59,251USD 1,914,400USD 1,914,4000USD 0 USD 32.31 USD 32.31
2025-02-14 (Friday)59,251USD 1,914,400RNA holding decreased by -42068USD 1,914,4000USD -42,068 USD 32.31 USD 33.02
2025-02-13 (Thursday)59,251RNA holding increased by 561USD 1,956,468RNA holding increased by 88365USD 1,956,468561USD 88,365 USD 33.02 USD 31.83
2025-02-12 (Wednesday)58,690RNA holding increased by 187USD 1,868,103RNA holding decreased by -108713USD 1,868,103187USD -108,713 USD 31.83 USD 33.79
2025-02-11 (Tuesday)58,503RNA holding increased by 748USD 1,976,816RNA holding decreased by -4758USD 1,976,816748USD -4,758 USD 33.79 USD 34.31
2025-02-10 (Monday)57,755USD 1,981,574RNA holding decreased by -35231USD 1,981,5740USD -35,231 USD 34.31 USD 34.92
2025-02-07 (Friday)57,755USD 2,016,805RNA holding decreased by -10973USD 2,016,8050USD -10,973 USD 34.92 USD 35.11
2025-02-06 (Thursday)57,755USD 2,027,778RNA holding increased by 24835USD 2,027,7780USD 24,835 USD 35.11 USD 34.68
2025-02-05 (Wednesday)57,755USD 2,002,943RNA holding increased by 77391USD 2,002,9430USD 77,391 USD 34.68 USD 33.34
2025-02-04 (Tuesday)57,755USD 1,925,552RNA holding increased by 79702USD 1,925,5520USD 79,702 USD 33.34 USD 31.96
2025-02-03 (Monday)57,755USD 1,845,850RNA holding decreased by -56022USD 1,845,8500USD -56,022 USD 31.96 USD 32.93
2025-01-31 (Friday)57,755USD 1,901,872RNA holding increased by 17326USD 1,901,8720USD 17,326 USD 32.93 USD 32.63
2025-01-30 (Thursday)57,755USD 1,884,546RNA holding increased by 41006USD 1,884,5460USD 41,006 USD 32.63 USD 31.92
2025-01-29 (Wednesday)57,755USD 1,843,540RNA holding decreased by -9240USD 1,843,5400USD -9,240 USD 31.92 USD 32.08
2025-01-28 (Tuesday)57,755USD 1,852,780RNA holding increased by 94718USD 1,852,7800USD 94,718 USD 32.08 USD 30.44
2025-01-27 (Monday)57,755USD 1,758,062RNA holding increased by 44471USD 1,758,0620USD 44,471 USD 30.44 USD 29.67
2025-01-24 (Friday)57,755USD 1,713,591RNA holding decreased by -26567USD 1,713,5910USD -26,567 USD 29.67 USD 30.13
2025-01-23 (Thursday)57,755USD 1,740,158RNA holding increased by 2888USD 1,740,1580USD 2,888 USD 30.13 USD 30.08
2025-01-22 (Wednesday)57,755USD 1,737,270USD 1,737,270
2025-01-21 (Tuesday)57,755USD 1,781,164USD 1,781,164
2025-01-20 (Monday)57,755USD 1,670,275USD 1,670,275
2025-01-17 (Friday)57,755USD 1,670,275USD 1,670,275
2025-01-16 (Thursday)57,007USD 1,612,728USD 1,612,728
2025-01-15 (Wednesday)56,259USD 1,567,938USD 1,567,938
2025-01-14 (Tuesday)56,259USD 1,521,806USD 1,521,806
2025-01-13 (Monday)56,259USD 1,598,318USD 1,598,318
2025-01-10 (Friday)56,259USD 1,657,390USD 1,657,390
2025-01-09 (Thursday)56,633USD 1,695,026USD 1,695,026
2025-01-09 (Thursday)56,633USD 1,695,026USD 1,695,026
2025-01-09 (Thursday)56,633USD 1,695,026USD 1,695,026
2025-01-08 (Wednesday)56,633USD 1,695,026USD 1,695,026
2025-01-08 (Wednesday)56,633USD 1,695,026USD 1,695,026
2025-01-08 (Wednesday)56,633USD 1,695,026USD 1,695,026
2025-01-02 (Thursday)57,381USD 1,789,140RNA holding increased by 114762USD 1,789,1400USD 114,762 USD 31.18 USD 29.18
2024-12-30 (Monday)57,381RNA holding decreased by -5441USD 1,674,378RNA holding decreased by -593496USD 1,674,378-5,441USD -593,496 USD 29.18 USD 36.1
2024-12-10 (Tuesday)62,822USD 2,267,874RNA holding decreased by -47117USD 2,267,8740USD -47,117 USD 36.1 USD 36.85
2024-12-09 (Monday)62,822USD 2,314,991RNA holding decreased by -89207USD 2,314,9910USD -89,207 USD 36.85 USD 38.27
2024-12-06 (Friday)62,822USD 2,404,198RNA holding increased by 87323USD 2,404,1980USD 87,323 USD 38.27 USD 36.88
2024-12-05 (Thursday)62,822USD 2,316,875RNA holding decreased by -65963USD 2,316,8750USD -65,963 USD 36.88 USD 37.93
2024-12-04 (Wednesday)62,822USD 2,382,838RNA holding decreased by -34553USD 2,382,8380USD -34,553 USD 37.93 USD 38.48
2024-12-03 (Tuesday)62,822USD 2,417,391RNA holding decreased by -177158USD 2,417,3910USD -177,158 USD 38.48 USD 41.3
2024-12-02 (Monday)62,822USD 2,594,549RNA holding decreased by -108682USD 2,594,5490USD -108,682 USD 41.3 USD 43.03
2024-11-29 (Friday)62,822USD 2,703,231RNA holding decreased by -18846USD 2,703,2310USD -18,846 USD 43.03 USD 43.33
2024-11-28 (Thursday)62,822USD 2,722,077USD 2,722,0770USD 0 USD 43.33 USD 43.33
2024-11-27 (Wednesday)62,822USD 2,722,077RNA holding decreased by -29527USD 2,722,0770USD -29,527 USD 43.33 USD 43.8
2024-11-26 (Tuesday)62,822USD 2,751,604RNA holding decreased by -83553USD 2,751,6040USD -83,553 USD 43.8 USD 45.13
2024-11-25 (Monday)62,822USD 2,835,157RNA holding increased by 118105USD 2,835,1570USD 118,105 USD 45.13 USD 43.25
2024-11-22 (Friday)62,822USD 2,717,052RNA holding increased by 43348USD 2,717,0520USD 43,348 USD 43.25 USD 42.56
2024-11-21 (Thursday)62,822USD 2,673,704RNA holding decreased by -68476USD 2,673,7040USD -68,476 USD 42.56 USD 43.65
2024-11-20 (Wednesday)62,822USD 2,742,180RNA holding increased by 25128USD 2,742,1800USD 25,128 USD 43.65 USD 43.25
2024-11-19 (Tuesday)62,822USD 2,717,052RNA holding increased by 119362USD 2,717,0520USD 119,362 USD 43.25 USD 41.35
2024-11-18 (Monday)62,822RNA holding decreased by -3015USD 2,597,690RNA holding decreased by -478873USD 2,597,690-3,015USD -478,873 USD 41.35 USD 46.73
2024-11-12 (Tuesday)65,837USD 3,076,563RNA holding increased by 658USD 3,076,5630USD 658 USD 46.73 USD 46.72
2024-11-08 (Friday)65,837RNA holding decreased by -201USD 3,075,905RNA holding decreased by -61560USD 3,075,905-201USD -61,560 USD 46.72 USD 47.51
2024-11-07 (Thursday)66,038USD 3,137,465RNA holding increased by 17830USD 3,137,4650USD 17,830 USD 47.51 USD 47.24
2024-11-06 (Wednesday)66,038USD 3,119,635RNA holding increased by 141982USD 3,119,6350USD 141,982 USD 47.24 USD 45.09
2024-11-05 (Tuesday)66,038USD 2,977,653RNA holding increased by 17830USD 2,977,6530USD 17,830 USD 45.09 USD 44.82
2024-11-04 (Monday)66,038USD 2,959,823RNA holding increased by 194812USD 2,959,8230USD 194,812 USD 44.82 USD 41.87
2024-11-01 (Friday)66,038USD 2,765,011RNA holding decreased by -25755USD 2,765,0110USD -25,755 USD 41.87 USD 42.26
2024-10-31 (Thursday)66,038USD 2,790,766RNA holding decreased by -63396USD 2,790,7660USD -63,396 USD 42.26 USD 43.22
2024-10-30 (Wednesday)66,038USD 2,854,162RNA holding decreased by -89152USD 2,854,1620USD -89,152 USD 43.22 USD 44.57
2024-10-29 (Tuesday)66,038USD 2,943,314RNA holding decreased by -75943USD 2,943,3140USD -75,943 USD 44.57 USD 45.72
2024-10-28 (Monday)66,038USD 3,019,257RNA holding increased by 40283USD 3,019,2570USD 40,283 USD 45.72 USD 45.11
2024-10-25 (Friday)66,038USD 2,978,974RNA holding decreased by -2642USD 2,978,9740USD -2,642 USD 45.11 USD 45.15
2024-10-24 (Thursday)66,038USD 2,981,616RNA holding decreased by -16509USD 2,981,6160USD -16,509 USD 45.15 USD 45.4
2024-10-23 (Wednesday)66,038USD 2,998,125RNA holding decreased by -130755USD 2,998,1250USD -130,755 USD 45.4 USD 47.38
2024-10-22 (Tuesday)66,038USD 3,128,880RNA holding increased by 44245USD 3,128,8800USD 44,245 USD 47.38 USD 46.71
2024-10-21 (Monday)66,038RNA holding decreased by -201USD 3,084,635RNA holding decreased by -257123USD 3,084,635-201USD -257,123 USD 46.71 USD 50.45
2024-10-18 (Friday)66,239USD 3,341,758USD 3,341,758
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of RNA by Blackrock for IE00BDZVHG35

Show aggregate share trades of RNA

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-04-23BUY200 30.680* 34.68
2025-04-10SELL-1,600 24.110* 35.48 Profit of 56,774 on sale
2025-04-08SELL-200 24.080* 35.74 Profit of 7,148 on sale
2025-04-07SELL-200 25.480* 35.86 Profit of 7,171 on sale
2025-04-04SELL-1,000 26.570* 35.97 Profit of 35,966 on sale
2025-04-01BUY1,748 26.740* 36.15
2025-03-31SELL-591 29.520* 36.23 Profit of 21,414 on sale
2025-03-21BUY2,995 30.840* 36.56
2025-03-14SELL-2,992 31.110* 36.91 Profit of 110,437 on sale
2025-03-07SELL-374 30.290* 37.36 Profit of 13,974 on sale
2025-03-04SELL-187 28.560* 37.74 Profit of 7,057 on sale
2025-02-25BUY374 29.160* 38.45
2025-02-19SELL-187 31.900* 38.96 Profit of 7,285 on sale
2025-02-13BUY561 33.020* 39.48
2025-02-12BUY187 31.830* 39.64
2025-02-11BUY748 33.790* 39.76
2024-12-30SELL-5,441 29.180* 43.15 Profit of 234,786 on sale
2024-11-18SELL-3,015 41.350* 45.34 Profit of 136,711 on sale
2024-11-08SELL-201 46.720* 45.15 Profit of 9,074 on sale
2024-10-21SELL-201 46.710* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of RNA

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-05-09397,09734464,77685.4%
2025-05-08761,4952341,082,33170.4%
2025-05-07369,0262,438761,08948.5%
2025-05-06907,88215,5391,622,97055.9%
2025-05-05179,49617279,28364.3%
2025-05-02408,668802589,35969.3%
2025-05-01310,460106352,25588.1%
2025-04-30227,85353329,07569.2%
2025-04-29215,636220298,47172.2%
2025-04-28183,870253265,80169.2%
2025-04-25223,6705,721359,71762.2%
2025-04-24233,079439509,60145.7%
2025-04-23393,822805485,61081.1%
2025-04-22542,024390881,75461.5%
2025-04-21399,3123,084553,97372.1%
2025-04-17299,969200780,33038.4%
2025-04-16290,460281398,63172.9%
2025-04-15203,633788431,61147.2%
2025-04-14208,090483391,04853.2%
2025-04-11319,8260435,22073.5%
2025-04-10299,2884,142598,75850.0%
2025-04-09535,49013,6021,557,58834.4%
2025-04-08569,28295861,34466.1%
2025-04-07432,834685816,52253.0%
2025-04-04507,72045799,82963.5%
2025-04-03664,6861541,011,47965.7%
2025-04-021,203,9036,2421,775,36667.8%
2025-04-01582,8282,4721,170,51149.8%
2025-03-311,090,8442681,592,24368.5%
2025-03-28233,043718272,76885.4%
2025-03-27460,852100524,23287.9%
2025-03-26487,1194,035541,42590.0%
2025-03-25328,4831,737410,01780.1%
2025-03-24370,2524,056403,38991.8%
2025-03-21200,226338248,23380.7%
2025-03-20363,7151,332629,76157.8%
2025-03-19187,68069362,61651.8%
2025-03-18415,9421,047557,40274.6%
2025-03-17384,71814,190557,38269.0%
2025-03-14434,2791,383549,31779.1%
2025-03-13471,2541,446747,05963.1%
2025-03-12356,1183,419533,69666.7%
2025-03-11246,772473349,12070.7%
2025-03-10206,439125294,19670.2%
2025-03-07227,754158326,61769.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.